Texas Capital Bancshares Inc increased its stake in Jp Morgan Chase & Co (JPM) by 64.7% based on its latest 2017Q3 regulatory filing with the SEC. Texas Capital Bancshares Inc bought 3,215 shares as the company’s stock declined 6.04% while stock markets rallied. The institutional investor held 8,184 shares of the major banks company at the end of 2017Q3, valued at $781,000, up from 4,969 at the end of the previous reported quarter. Texas Capital Bancshares Inc who had been investing in Jp Morgan Chase & Co for a number of months, seems to be bullish on the $393.73 billion market cap company. The stock increased 0.09% or $0.1 during the last trading session, reaching $114.74. About 13.63 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since March 22, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.
Jim Roumell decreased its stake in Paratek Pharmaceuticals Inc (PRTK) by 60.66% based on its latest 2017Q3 regulatory filing with the SEC. Roumell Asset Management Llc sold 156,349 shares as the company’s stock rose 33.85% with the market. The hedge fund run by Jim Roumell held 101,399 shares of the health care company at the end of 2017Q3, valued at $2.55 million, down from 257,748 at the end of the previous reported quarter. Roumell Asset Management Llc who had been investing in Paratek Pharmaceuticals Inc for a number of months, seems to be less bullish one the $426.05M market cap company. The stock increased 0.74% or $0.1 during the last trading session, reaching $13.55. About 200,419 shares traded. Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) has risen 62.03% since March 22, 2017 and is uptrending. It has outperformed by 45.33% the S&P500.
Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.28, from 1.19 in 2017Q2. It is negative, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. Gam Ag reported 26,734 shares. Pnc Gp stated it has 1.04% in JPMorgan Chase & Co. (NYSE:JPM). Boston Common Asset Management Limited Liability Company invested 2.29% in JPMorgan Chase & Co. (NYSE:JPM). Bedrijfstakpensioenfonds Voor De Media Pno invested 3.5% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Eagle Global stated it has 0.5% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Tiedemann Wealth Management Limited Liability Corp invested in 81,842 shares or 0.56% of the stock. Martin Currie Limited reported 182,158 shares. Marble Harbor Invest Counsel Llc holds 0.05% or 2,646 shares. Jnba Financial Advsrs stated it has 0.23% in JPMorgan Chase & Co. (NYSE:JPM). Tiger Ltd Com holds 239,600 shares. Segment Wealth Mgmt Ltd Liability Company invested in 1.25% or 49,379 shares. Thompson Siegel & Walmsley Lc holds 0.14% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 119,660 shares. Estabrook Capital Mngmt invested in 333,536 shares. California State Teachers Retirement Systems owns 6.22M shares or 1.32% of their US portfolio. Pictet Asset Management Ltd invested 0.61% in JPMorgan Chase & Co. (NYSE:JPM).
Since October 25, 2017, it had 1 buy, and 9 insider sales for $22.34 million activity. Friedman Stacey had sold 2,099 shares worth $214,019. The insider Petno Douglas B sold $5.43 million. 9,194 JPMorgan Chase & Co. (NYSE:JPM) shares with value of $1.03M were sold by Lake Marianne. On Tuesday, January 16 the insider CROWN JAMES S bought $825,327. 65,101 shares were sold by Erdoes Mary E., worth $7.31 million on Saturday, January 13. Giles Nicole also sold $425,399 worth of JPMorgan Chase & Co. (NYSE:JPM) shares.
Among 33 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 13 Hold. Therefore 55% are positive. JPMorgan Chase & Co had 114 analyst reports since July 21, 2015 according to SRatingsIntel. On Monday, January 18 the stock rating was maintained by UBS with “Neutral”. The rating was upgraded by Keefe Bruyette & Woods to “Buy” on Tuesday, February 13. The rating was upgraded by Atlantic Securities on Friday, January 15 to “Overweight”. The firm earned “Buy” rating on Wednesday, January 24 by Credit Suisse. The company was maintained on Thursday, June 15 by RBC Capital Markets. The firm has “Buy” rating by Argus Research given on Friday, January 15. The firm has “Neutral” rating given on Wednesday, February 28 by Nomura. The stock of JPMorgan Chase & Co. (NYSE:JPM) earned “Buy” rating by RBC Capital Markets on Monday, November 13. The firm has “Neutral” rating by Robert W. Baird given on Wednesday, November 9. Bruyette & Woods” upgraded JPMorgan Chase & Co. (NYSE:JPM) on Monday, August 17 to “Outperform” rating.
Roumell Asset Management Llc, which manages about $293.14 million and $42.50 million US Long portfolio, upped its stake in Rosetta Stone Inc (NYSE:RST) by 170,622 shares to 767,625 shares, valued at $7.84 million in 2017Q3, according to the filing. It also increased its holding in Great Elm Cap Group Inc by 302,074 shares in the quarter, for a total of 363,799 shares, and has risen its stake in Rubicon Proj Inc (NYSE:RUBI).
Analysts await Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) to report earnings on May, 3. They expect $-0.95 earnings per share, up 16.67% or $0.19 from last year’s $-1.14 per share. After $-0.78 actual earnings per share reported by Paratek Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 21.79% negative EPS growth.